- 1002/14651858.CD010341.pub2. PMC 9465394. PMID 26625332.
Listl S,
Jansen L,
Stenzinger A,
Freier K,
Emrich K,
Holleczek B, et al. (GEKID
Cancer Survival Working...
-
Nielsen GP,
Takano A,
Suurmeijer AJ,
Voltaggio L,
Zhang L, Sung YS,
Stenzinger A,
Mechtersheimer G, ****son BC,
Antonescu CR (November 2020). "EWSR1/FUS-CREB...
- A,
Lorenz K,
Budczies J,
Penzel R,
Lennerz JK,
Endris V,
Weichert W,
Stenzinger A (February 2016). "Mutations in
genes encoding PI3K-AKT and MAPK signaling...
- 1124/dmd.106.009902. PMID 16679390. S2CID 1225633. Noll EM,
Eisen C,
Stenzinger A,
Espinet E,
Muckenhuber A,
Klein C, et al. (March 2016). "CYP3A5 mediates...
-
Regulator of
microtubule dynamics protein 3". Koch P,
Petri M,
Paradowska A,
Stenzinger A,
Sturm K,
Steger K,
Wimmer M (Dec 2009). "PTPIP51 mRNA and
protein expression...
-
February 18, 2021. Chan TA,
Yarchoan M,
Jaffee E,
Swanton C,
Quezada SA,
Stenzinger A, et al. (2019). "Development of
tumor mutation burden as an immunotherapy...
- PMID 22073420. {{cite journal}}: Cite
journal requires |journal= (help)
Stenzinger, W; Blömker, A; Hiddemann, W; de Loo, J (1990). "Treatment of refractory...
-
Nielsen GP,
Takano A,
Suurmeijer AJ,
Voltaggio L,
Zhang L, Sung YS,
Stenzinger A,
Mechtersheimer G, ****son BC,
Antonescu CR (November 2020). "EWSR1/FUS-CREB...
- A,
Dietel M,
Schmidt SC,
Glanemann M,
Bahra M,
Neuhaus P,
Weichert W,
Stenzinger A (Jan 2012). "Prolyl
hydroxylase domain 2
protein is a
strong prognostic...
